Revanesse® Hyaluronic Acid Dermal Fillers

Subtle by Design. Engineered for Your Technique

Revanesse® dermal fillers represent a refined approach to hyaluronic acid (HA) injectables, engineered to support precision-led aesthetic practice through purity, particle architecture, and injection performance.

Developed by Prollenium in Canada, Revanesse® is built for practitioners who prioritise control, consistency, and subtle, natural outcomes across all treatment indications.

Why Revanesse® in Clinical Practice

Predictability Through Precision Engineering

Revanesse® is manufactured in controlled small batches, ensuring consistency in gel structure and performance. This translates clinically into:

Reliable projection and tissue integration
Consistent extrusion across syringes
Reproducible results across patients and treatment areas

For practitioners, this reduces variability, allowing the technique to remain the defining factor.

Minimal Swelling. Clean Outcomes

A key differentiator in Revanesse® is its low inflammatory profile, achieved through:

High molecular weight HA
Low residual BDDE levels
Extended purification process (7 days)

This results in:

More accurate immediate assessment of results
Reduced post-injection oedema
Faster patient recovery

The Science Behind Revanesse®

Wet Milling & Spherical Particle Formation

Revanesse® utilises a proprietary wet-milling process, an additional, time-intensive manufacturing step that refines HA into uniform, spherical particles.

Unlike irregular particle structures, spherical HA offers:

Lower surface area → reduced inflammatory response
Smoother gel consistency
Enhanced tissue integration
Greater predictability during placement

This process is fundamental to achieving subtle, controlled volumisation. The smooth, uniform particles promote better tissue integration and reduce the risk of a foreign-body reaction.

Thixofix® Technology: Balanced Rheology

Revanesse® is built on Thixofix® cross-linking technology, combining:

High molecular weight HA
Low cross-linking agent (BDDE)
Homogeneous, round particle distribution

The result is a gel with balanced viscoelastic properties, allowing:

Controlled flow under pressure
Stability at rest within tissue
Precision placement across superficial and deep planes

Optimised for your technique, not against it.

Injection Experience: Designed for Control

Glass Syringe & Optimised Extrusion

Revanesse® is delivered in a high-quality glass syringe, contributing to:

Smooth, consistent plunger movement
Reduced extrusion force
Enhanced tactile feedback during injection

This improves practitioner control, particularly in delicate or high-precision areas such as the periorbital and perioral regions.

Subtle Efficiency in Practice

Revanesse® syringes are designed with practical volume considerations, offering more product per syringe while maintaining competitive positioning. For clinics, this supports:

Enhanced workflow without compromising outcomes
Treatment efficiency
Fewer syringe changes during procedures

Clinical Versatility Across Indications

Revanesse® supports a full spectrum of aesthetic treatments, including:

Structural volumisation (midface, temples)
Contouring and definition (jawline, chin)
Fine line and superficial correction
Lip enhancement and refinement

Its adaptable rheology allows practitioners to layer treatments with confidence, supporting combination approaches.